Biblio

Export 234 results:
[ Author(Asc)] Title Type Year
Filters: First Letter Of Last Name is L  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
L
Y. Li, Li, Z. - X., Jin, T., Wang, Z. - Y., and Zhao, P., “Tau Pathology Promotes the Reorganization of the Extracellular Matrix and Inhibits the Formation of Perineuronal Nets by Regulating the Expression and the Distribution of Hyaluronic Acid Synthases.”, J Alzheimers Dis, vol. 57, no. 2, pp. 395-409, 2017.
H. Li, Zhu, H., Wallack, M., Mwamburi, M., Abdul-Hay, S. O., Leissring, M. A., and Qiu, W. Qiao, “Age and its association with low insulin and high amyloid-β peptides in blood.”, J Alzheimers Dis, vol. 49, no. 1, pp. 129-37, 2016.
Y. Li, Chen, X., Zhou, M., Feng, S., Peng, X., and Wang, Y., “Microglial TLR4/NLRP3 Inflammasome Signaling in Alzheimer's Disease.”, J Alzheimers Dis, vol. 97, no. 1, pp. 75-88, 2024.
C. Li, Duara, R., Loewenstein, D. A., Izquierdo, W., Cabrerizo, M., Barker, W., and Adjouadi, M., “Greater Regional Cortical Thickness is Associated with Selective Vulnerability to Atrophy in Alzheimer's Disease, Independent of Amyloid Load and APOE Genotype.”, J Alzheimers Dis, vol. 69, no. 1, pp. 145-156, 2019.
C. Li, Neugroschl, J., Luo, X., Zhu, C., Aisen, P., Ferris, S., and Sano, M., “The Utility of the Cognitive Function Instrument (CFI) to Detect Cognitive Decline in Non-Demented Older Adults.”, J Alzheimers Dis, vol. 60, no. 2, pp. 427-437, 2017.
B. Li, Xu, P., Wu, S., Jiang, Z., Huang, Z., Li, Q., and Chen, D., “Diosgenin Attenuates Lipopolysaccharide-Induced Parkinson's Disease by Inhibiting the TLR/NF-κB Pathway.”, J Alzheimers Dis, vol. 64, no. 3, pp. 943-955, 2018.
X. Li, Song, Y., Sanders, C. R., and Buxbaum, J. N., “Transthyretin Suppresses Amyloid-β Secretion by Interfering with Processing of the Amyloid-β Protein Precursor.”, J Alzheimers Dis, vol. 52, no. 4, pp. 1263-75, 2016.
D. Li, Huang, Y., Cheng, B., Su, J., Zhou, W. - X., and Zhang, Y. - X., “Streptozotocin Induces Mild Cognitive Impairment at Appropriate Doses in Mice as Determined by Long-Term Potentiation and the Morris Water Maze.”, J Alzheimers Dis, vol. 54, no. 1, pp. 89-98, 2016.
Q. - X. Li, Villemagne, V. L., Doecke, J. D., Rembach, A., Sarros, S., Varghese, S., McGlade, A., Laughton, K. M., Pertile, K. K., Fowler, C. J., Rumble, R. L., Trounson, B. O., Taddei, K., Rainey-Smith, S. R., Laws, S. M., Robertson, J. S., Evered, L. A., Silbert, B., Ellis, K. A., Rowe, C. C., S Macaulay, L., Darby, D., Martins, R. N., Ames, D., Masters, C. L., and Collins, S., “Alzheimer's Disease Normative Cerebrospinal Fluid Biomarkers Validated in PET Amyloid-β Characterized Subjects from the Australian Imaging, Biomarkers and Lifestyle (AIBL) study.”, J Alzheimers Dis, vol. 48, no. 1, pp. 175-87, 2015.
J. Li, Long, X., Huang, H., Tang, J., Zhu, C., Hu, S., Wu, J., Li, J., Lin, Z., and Xiong, N., “Resilience of Alzheimer's Disease to COVID-19.”, J Alzheimers Dis, vol. 77, no. 1, pp. 67-73, 2020.
H. Li, Jia, J., and Yang, Z., “Mini-Mental State Examination in Elderly Chinese: A Population-Based Normative Study.”, J Alzheimers Dis, vol. 53, no. 2, pp. 487-96, 2016.
Z. Li, Fan, Z., and Zhang, Q., “The Associations of Phosphorylated Tau 181 and Tau 231 Levels in Plasma and Cerebrospinal Fluid with Cognitive Function in Alzheimer's Disease: A Systematic Review and Meta-Analysis.”, J Alzheimers Dis, vol. 98, no. 1, pp. 13-32, 2024.
J. Li, Ogrodnik, M., Kolachalama, V. B., Lin, H., and Au, R., “Assessment of the Mid-Life Demographic and Lifestyle Risk Factors of Dementia Using Data from the Framingham Heart Study Offspring Cohort.”, J Alzheimers Dis, vol. 63, no. 3, pp. 1119-1127, 2018.
J. Li, Wang, Y. J., Zhang, M., Xu, Z. Q., Gao, C. Y., Fang, C. Q., Yan, J. C., and Zhou, H. D., “Vascular risk factors promote conversion from mild cognitive impairment to Alzheimer disease.”, Neurology, vol. 76, no. 17, pp. 1485-91, 2011.
X. Li, Westman, E., Thordardottir, S., Ståhlbom, A. Kinhult, Almkvist, O., Blennow, K., Wahlund, L. - O., and Graff, C., “The Effects of Gene Mutations on Default Mode Network in Familial Alzheimer's Disease.”, J Alzheimers Dis, vol. 56, no. 1, pp. 327-334, 2017.
L. - L. Li, Ma, Y. - H., Bi, Y. - L., Sun, F. - R., Hu, H., Hou, X. - H., Xu, W., Shen, X. - N., Dong, Q., Tan, L., Yang, J. - L., and Yu, J. - T., “Serum Uric Acid May Aggravate Alzheimer's Disease Risk by Affecting Amyloidosis in Cognitively Intact Older Adults: The CABLE Study.”, J Alzheimers Dis, vol. 81, no. 1, pp. 389-401, 2021.
D. Li, Hu, N., Yu, Y., Zhou, A., Li, F., and Jia, J., “Trajectories of Multidimensional Caregiver Burden in Chinese Informal Caregivers for Dementia: Evidence from Exploratory and Confirmatory Factor Analysis of the Zarit Burden Interview.”, J Alzheimers Dis, vol. 59, no. 4, pp. 1317-1325, 2017.
H. Li, Jia, J., Wang, W., Hou, T., Tian, Y., Wu, Q., Xu, L., Wei, Y., and Wang, X., “Honokiol Alleviates Cognitive Deficits of Alzheimer's Disease (PS1V97L) Transgenic Mice by Activating Mitochondrial SIRT3.”, J Alzheimers Dis, vol. 64, no. 1, pp. 291-302, 2018.
W. Li and Huang, E., “An Update on Type 2 Diabetes Mellitus as a Risk Factor for Dementia.”, J Alzheimers Dis, vol. 53, no. 2, pp. 393-402, 2016.
X. Li, Jia, S., Zhou, Z., Hou, C., Zheng, W., Rong, P., and Jiao, J., “The Gesture Imitation in Alzheimer's Disease Dementia and Amnestic Mild Cognitive Impairment.”, J Alzheimers Dis, vol. 53, no. 4, pp. 1577-84, 2016.
W. - X. Li, Dai, S. - X., Liu, J. - Q., Wang, Q., Li, G. - H., and Huang, J. - F., “Integrated Analysis of Alzheimer's Disease and Schizophrenia Dataset Revealed Different Expression Pattern in Learning and Memory.”, J Alzheimers Dis, vol. 51, no. 2, pp. 417-25, 2016.
P. Lewczuk, Lelental, N., Lachmann, I., Holzer, M., Flach, K., Brandner, S., Engelborghs, S., Teunissen, C. E., Zetterberg, H., Molinuevo, J. Luis, Mroczko, B., Blennow, K., Popp, J., Parnetti, L., Chiasserini, D., Perret-Liaudet, A., Spitzer, P., Maler, J. Manuel, and Kornhuber, J., “Non-Phosphorylated Tau as a Potential Biomarker of Alzheimer's Disease: Analytical and Diagnostic Characterization.”, J Alzheimers Dis, vol. 55, no. 1, pp. 159-170, 2017.
P. Lewczuk, Matzen, A., Blennow, K., Parnetti, L., Molinuevo, J. Luis, Eusebi, P., Kornhuber, J., Morris, J. C., and Fagan, A. M., “Cerebrospinal Fluid Aβ42/40 Corresponds Better than Aβ42 to Amyloid PET in Alzheimer's Disease.”, J Alzheimers Dis, vol. 55, no. 2, pp. 813-822, 2017.
B. Levy, Tsoy, E., and Gable, S., “Developing Cognitive Markers of Alzheimer's Disease for Primary Care: Implications for Behavioral and Global Prevention.”, J Alzheimers Dis, vol. 54, no. 4, pp. 1259-1272, 2016.
D. A. Levine, Gross, A. L., Briceño, E. M., Tilton, N., Whitney, R., Han, D., Giordani, B. J., Sussman, J. B., Hayward, R. A., Burke, J. F., Elkind, M. S. V., Moran, A. E., Tom, S., Gottesman, R. F., Gaskin, D. J., Sidney, S., Yaffe, K., Sacco, R. L., Heckbert, S. R., Hughes, T. M., Lopez, O. L., Allen, N. Bai, and Galecki, A. T., “Blood Pressure and Later-Life Cognition in Hispanic and White Adults (BP-COG): A Pooled Cohort Analysis of ARIC, CARDIA, CHS, FOS, MESA, and NOMAS.”, J Alzheimers Dis, vol. 89, no. 3, pp. 1103-1117, 2022.

Pages